Your browser doesn't support javascript.
loading
Amplification of Cerenkov luminescence using semiconducting polymers for cancer theranostics.
Rosenkrans, Zachary T; Hsu, Jessica C; Aluicio-Sarduy, Eduardo; Barnhart, Todd E; Engle, Jonathan W; Cai, Weibo.
Afiliação
  • Rosenkrans ZT; University of Wisconsin-Madison, Department of Pharmaceutical Sciences, 600 Highland Ave., K6/562, Madison, WI 53792, USA.
  • Hsu JC; University of Wisconsin-Madison, Departments of Radiology and Medical Physics, Madison, WI 53705, USA.
  • Aluicio-Sarduy E; University of Wisconsin-Madison, Departments of Radiology and Medical Physics, Madison, WI 53705, USA.
  • Barnhart TE; University of Wisconsin-Madison, Departments of Radiology and Medical Physics, Madison, WI 53705, USA.
  • Engle JW; University of Wisconsin-Madison, Departments of Radiology and Medical Physics, Madison, WI 53705, USA.
  • Cai W; University of Wisconsin-Madison, Carbone Cancer Center, Madison, WI 53705, USA.
Adv Funct Mater ; 33(33)2023 Aug 15.
Article em En | MEDLINE | ID: mdl-37942189
ABSTRACT
The therapeutic efficacy of photodynamic therapy is limited by the ability of light to penetrate tissues. Due to this limitation, Cerenkov luminescence (CL) from radionuclides has recently been proposed as an alternative light source in a strategy referred to as Cerenkov radiation induced therapy (CRIT). Semiconducting polymer nanoparticles (SPNs) have ideal optical properties, such as large absorption cross-sections and broad absorbance, which can be utilized to harness the relatively weak CL produced by radionuclides. SPNs can be doped with photosensitizers and have nearly 100% energy transfer efficiency by multiple energy transfer mechanisms. Herein, we investigated an optimized photosensitizer doped SPN as a nanosystem to harness and amplify CL for cancer theranostics. We found that semiconducting polymers significantly amplified CL energy transfer efficiency. Bimodal PET and optical imaging studies showed high tumor uptake and retention of the optimized SPNs when administered intravenously or intratumorally. Lastly, we found that photosensitizer doped SPNs have excellent potential as a cancer theranostics nanosystem in an in vivo tumor therapy study. Our study shows that SPNs are ideally suited to harness and amplify CL for cancer theranostics, which may provide a significant advancement for CRIT that are unabated by tissue penetration limits.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article